Study of the involvement of AMPA receptors in the antihypoxic effect of the neuropeptide cyclo-prolyl-glycine
- Authors: Koliasnikova K.N1, Alyaeva A.G1, Vorontsova O.N1, Gudasheva T.A1
-
Affiliations:
- FSBI «Zakusov Institute of Pharmacology»
- Issue: Vol 23, No 9 (2020)
- Pages: 42-45
- Section: Articles
- URL: https://journals.eco-vector.com/1560-9596/article/view/112781
- DOI: https://doi.org/10.29296/25877313-2020-09-06
- ID: 112781
Cite item
Open Access
Access granted
Abstract
Relevance. Cyclo-prolyl-glycine (CPG) was designed and synthesized at the Zakusov Research Institute of Pharmacology as a topological analogue of the nootropic drug piracetam and was later discovered as an endogenous compound in the rat brain. It had a spectrum of pharmacological characteristics of piracetam, including antihypoxic activity. However, there is still no evident data of the mechanism of action of this neuropeptide. Therefore, clarification of the mechanism of action of CPG is relevant. Objective. Purpose of the study is to reveal the involvement of AMPA receptors in the antihypoxic effect of the neuropeptide CPG. Material and methods. The method of inhibitory pharmacological analysis using a selective antagonist of AMPA receptors of the compound DNQX was used. Antihypoxic activity was evaluated on a normobaric hypoxia model with hypercapnia in BALB/c mice. Results. The antihypoxic effect of CPG at the dose of 1 mg/kg intraperitoneally was completely removed by a specific blocker of AMPA receptors, compound DNQX, at the dose of 10 mg/kg intraperitoneally. Conclusions. For the first time it was shown that AMPA receptors are involved in the antihypoxic effect of the neuropeptide cyclo-prolyl-glycine.
Keywords
Full Text
About the authors
K. N Koliasnikova
FSBI «Zakusov Institute of Pharmacology»Ph.D. (Biol.) Moscow
A. G Alyaeva
FSBI «Zakusov Institute of Pharmacology»Junior Research Scientist Moscow
O. N Vorontsova
FSBI «Zakusov Institute of Pharmacology»Ph.D. (Biol.) Moscow
T. A Gudasheva
FSBI «Zakusov Institute of Pharmacology»
Email: tata-sosnovka@mail.ru
Dr.Sc. (Biol.), Professor, Corr. Member RAS Moscow
References
- Гудашева Т.А., Островская Р.У., Максимова Ф.В., Чуппин А.В., Трофимов С.С., Лезина В.П., Воронина Т.А., Сколдинов А.П. Топологические аналоги пирацетама на основе пролина и их ноотропная активность. Химико-фармацевтический журнал. 1989; 23(3): 276-281.
- Gudasheva T.A., Boyko S.S., Akparov V.Kh., Ostrovskaya R. U., Skoldinov A.P., Rozantsev G.G., Voronina T.A., Zherdev V.P., Seredenin S.B. Identification of a novel endogenous memory facilitating cyclic dipeptide cyclo-prolylglycine in rat brain. FEBS Letters. 1996; 391: 149-152.
- Гудашева Т.А., Константинопольский М.А., Островская Р.У., Середенин С.Б. Анксиолитическая активность эндогенного ноотропа цикло-пролилглицина в тесте приподнятого крестообразного лабиринта стереоселективна. Бюл. экспер. биол. мед. 2001; 131(5): 547-550.
- Guan J., Gluckman P., Yang P. et al. Cyclic glycine-proline regulates IGF-1 homeostasis by altering the binding of IGFBP-3 to IGF-1. Scientific reports. 2014. 4: 4388.
- Колясникова К.Н., Гудашева Т.А., Назарова Г.А. и др. Сходство цикло-пролилглицина с пирацетамом по антигипоксическому и нейропротекторному эффектам. Экспер. клин. фармакол. 2012; 75(9): 3-6.
- Guan J., Singh-Mallah G., Liu K. et al. The role for cyclic Glycine-Proline, a biological regulator of insulin-like growth factor-1 in pregnancy-related obesity and weight changes // J. Biol. Regul. Homeost. Agents. 2018;32(3):465-478.
- Гудашева Т.А., Григорьев В.В., Колясникова К.Н., Замойский В.Л., Середенин С.Б. Нейропептид цикло-пролилглицин является эндогенным положительным модулятором АМРА-рецепторов. Доклады Академии наук. 2016; 471(1): 106-108.
- Гудашева Т.А., Колясникова К.Н., Антипова Т.А., Середенин С.Б. Нейропептид циклопролилглицин увеличивает содержание мозгового нейротрофического фактора в нейрональных клетках. Доклады Академии наук. 2016; 469(4): 492-495.
- Aguado-Llera D., Canelles S., Fernandez-Mendivil C. et al. Improvement in inflammation is associated with the protective effect of Gly-Pro-Glu and cycloprolylglycine against Aß-induced depletion of the hippocampal somatostatinergic system. Neuropharmacology. 2019. 151. 112-126.
- Rial D., Takahashi R.N., Morato G.S. Aniracetam and DNQX affect the acquisition of rapid tolerance to ethanol in mice. Pharmacol Biochem Behav. 2009; 92(1): 32-38. doi: 10.1016/j.pbb.2008.10.006.
Supplementary files
